scholarly journals Systematic review of the stage of innovation of biological mesh for complex or contaminated abdominal wall closure

BJS Open ◽  
2018 ◽  
Vol 2 (6) ◽  
pp. 371-380 ◽  
Author(s):  
S. K. Kamarajah ◽  
S. J. Chapman ◽  
J. Glasbey ◽  
D. Morton ◽  
N. Smart ◽  
...  
Keyword(s):  
Systematic Review ◽  
Abdominal Wall ◽  
Biological Mesh ◽  
Abdominal Wall Closure

Biological Mesh in Contaminated Fields—Overuse without Data: A Systematic Review of Their Use in Abdominal Wall Reconstruction

2014 ◽  
Vol 80 (1) ◽  
pp. 3-8 ◽  
Author(s):  
Wirt Cross ◽  
Ajay Kumar ◽  
Gopal Chandru Kowdley
Keyword(s):  
Systematic Review ◽  
Hernia Repair ◽  
Abdominal Wall ◽  
English Language ◽  
Human Subjects ◽  
Abdominal Wall Reconstruction ◽  
Case Series ◽  
Biological Mesh ◽  
End Points ◽  
Scientific Papers

Ventral hernia repair in contaminated fields is a significant problem for surgeons. We performed a systematic review regarding the use of biological mesh in contaminated fields for abdominal wall reconstruction. The primary end points were recurrence and infection of the hernia repair. An independent search of scientific papers in the English language was performed by three reviewers. Articles were chosen based on reference to ventral hernias, their use in infected fields, and in human subjects. Papers were scored using the Methodological Index for Non-Randomized Studies and those with a score of 8 or more were combined to evaluate the end points. A total of 16 studies from six different mesh products met our criteria. These papers comprised 554 patients with an overall infection rate of 24 per cent and a recurrence rate of 20 per cent. The largest study used 116 patients. All papers were case series. Overall the data for use of biological mesh products in contaminated fields are limited. Further controlled studies are needed to address this important and clinically relevant question. Caution should be used when using biological mesh products in infected fields because there is a paucity of controlled data and none have U.S. Food and Drug Administration approval for use in infected fields.

scholarly journals Allotransplantation of donor rectus fascia for abdominal wall closure in transplant patients: A systematic review

2021 ◽  
pp. 100634
Author(s):  
Yveline Janssen ◽  
Nele Van De Winkel ◽  
Jacques Pirenne ◽  
Laurens J. Ceulemans ◽  
Marc Miserez
Keyword(s):  
Systematic Review ◽  
Abdominal Wall ◽  
Abdominal Wall Closure ◽  
Transplant Patients ◽  
Rectus Fascia

Chemotherapy and Abdominal Wall Closure Technique Increase the Probability of Postoperative Ventral Incisional Hernia in Patients With Colon Cancer

2021 ◽  
pp. 000313482110111
Author(s):  
David A. Santos ◽  
Liangliang Zhang ◽  
Kim-Anh Do ◽  
Brian K. Bednarski ◽  
Celia Robinson Ledet ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Colon Cancer ◽  
Adjuvant Chemotherapy ◽  
Incisional Hernia ◽  
Abdominal Wall ◽  
Suture Technique ◽  
Abdominal Wall Closure ◽  
Clinical Predictors ◽  
Closure Technique ◽  
Ventral Incisional Hernia

Background Chemotherapy is associated with postoperative ventral incisional hernia (PVIH) after right hemicolectomy (RHC) for colon cancer, and abdominal wall closure technique may affect PVIH. We sought to identify clinical predictors of PVIH. Methods We retrospectively analyzed patients who underwent RHC for colon cancer from 2008-2018 and later developed PVIH. Time to PVIH was analyzed with Kaplan-Meier analysis, clinical predictors were identified with multivariable Cox proportional hazards modeling, and the probability of PVIH given chemotherapy and the suture technique was estimated with Bayesian analysis. Results We identified 399 patients (209 no adjuvant chemotherapy and 190 adjuvant chemotherapy), with an overall PVIH rate of 38%. The 5-year PVIH rate was 55% for adjuvant chemotherapy, compared with 38% for none (log-rank P < .05). Adjuvant chemotherapy (hazard ratio [HR] 1.65, 95% confidence interval [CI] 1.18-2.31, P < .01), age (HR .99, 95% CI .97-1.00, P < .01), body mass index (HR 1.02, 95% CI 1.00-1.04, P < .01), and neoadjuvant chemotherapy (HR 1.92, 95% CI 1.21-3.00, P < .01) were independently associated with PVIH. Postoperative ventral incisional hernia was more common overall in patients who received adjuvant chemotherapy (46% compared with 30%, P < .01). In patients who received adjuvant chemotherapy, the probability of PVIH for incision closure with #1 running looped polydioxanone was 42%, compared with 59% for incision closure with #0 single interrupted polyglactin 910. Discussion Exposure to chemotherapy increases the probability of PVIH after RHC, and non–short stitch incision closure further increases this probability, more so than age or body mass index. The suture technique deserves further study as a modifiable factor in this high-risk population.

scholarly journals Commentary: Evidence for Replacement of an Infected Synthetic by a Biological Mesh in Abdominal Wall Hernia Repair

2017 ◽  
Vol 4 ◽  
Author(s):  
Ekaterini Christina Tampaki ◽  
Athanasios Tampakis ◽  
Konstantinos Kontzoglou ◽  
Gregory Kouraklis
Keyword(s):  
Hernia Repair ◽  
Abdominal Wall ◽  
Abdominal Wall Hernia ◽  
Biological Mesh ◽  
Abdominal Wall Hernia Repair

Cerebrospinal fluid shunt insertion: techniques of peritoneal catheter placement separate from abdominal fascial and peritoneal incisions

2010 ◽  
Vol 113 (1) ◽  
pp. 79-81 ◽  
Author(s):  
Abdurrahim A. Elashaal ◽  
Michael Corrin ◽  
Michael D. Cusimano
Keyword(s):  
Abdominal Wall ◽  
Csf Shunt ◽  
Abdominal Wall Closure ◽  
Peritoneal Catheter ◽  
Effective Technique ◽  
Shunt Insertion ◽  
Risk Patients ◽  
Abdominal Operations ◽  
Insertion Techniques ◽  
Almost All

Good abdominal wall closure is one of the basic surgical skills and is a common feature of almost all modernday CSF shunt operations. The fact that some patients require multiple abdominal operations highlights the need for a simple and effective technique for peritoneal catheter insertion through the abdominal wall and abdominal wall closure. Although technically simple, abdominal wall closure becomes more complex when combined with the requirement to maintain CSF shunt function in cases in which the shunt catheter passes through the abdominal wall into the peritoneal cavity. In this report, the authors describe a simple technique for passing the peritoneal catheter of a ventriculoperitoneal shunt through the abdominal wall on a pathway separate from the fascial opening. This technique minimizes the risk of abdominal wall–related complications and is especially important in high-risk patients such as those with obesity and/or diabetes and in children.

Sign in / Sign up

Export Citation Format

Share Document